Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Current Assets: 2020-2024

Historic Current Assets for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $809.2 million.

  • Relay Therapeutics' Current Assets fell 27.87% to $624.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $624.0 million, marking a year-over-year decrease of 27.87%. This contributed to the annual value of $809.2 million for FY2024, which is 5.08% up from last year.
  • Latest data reveals that Relay Therapeutics reported Current Assets of $809.2 million as of FY2024, which was up 5.08% from $770.1 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Current Assets registered a high of $1.0 billion during FY2022, and its lowest value of $770.1 million during FY2020.
  • Over the past 3 years, Relay Therapeutics' median Current Assets value was $809.2 million (recorded in 2024), while the average stood at $866.3 million.
  • As far as peak fluctuations go, Relay Therapeutics' Current Assets grew by 26.77% in 2021, and later decreased by 24.46% in 2023.
  • Yearly analysis of 5 years shows Relay Therapeutics' Current Assets stood at $770.1 million in 2020, then rose by 26.77% to $976.2 million in 2021, then grew by 4.43% to $1.0 billion in 2022, then decreased by 24.46% to $770.1 million in 2023, then climbed by 5.08% to $809.2 million in 2024.